A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated

NCT06148948 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-11-13

No results posted yet for this study

Summary

The goal of this trial is to investigate safety, tolerability and pharmacokinetics of BI 1584862 in healthy male subjects of Japanese ethnicity following oral administration of single rising doses.

Conditions

  • Healthy

Interventions

DRUG

BI 1584862

BI 1584862

DRUG

Placebo

Placebo matching BI 1584862

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-25
Primary Completion
2024-05-21
Completion
2024-05-21

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06148948 on ClinicalTrials.gov